Marco Meloni Selected Research

Foot Ulcer

12/2022	Macrophage Activation and M2 Polarization in Wound Bed of Diabetic Patients Treated by Dermal/Epidermal Substitute Nevelia.
10/2021	Characteristics of new patient referrals to specialised diabetic foot units across Europe and factors influencing delays.
9/2021	Foot Revascularization Avoids Major Amputation in Persons with Diabetes and Ischaemic Foot Ulcers.
11/2020	Multidisciplinary Approach for the Management and Treatment of Diabetic Foot Infections with a Resorbable, Gentamicin-Loaded Bone Graft Substitute.
9/2020	Limb Salvage in Diabetic Patients With Ischemic Heel Ulcers.
1/2019	Letter Regarding "The Prostacyclin Analogue Iloprost as an Early Predictor of Successful Revascularization in Diabetic Patients Affected by Critical Limb Ischemia and Foot Ulcers".
3/2018	Impact of heart failure and dialysis in the prognosis of diabetic patients with ischemic foot ulcers.
6/2016	Long term outcomes of diabetic haemodialysis patients with critical limb ischemia and foot ulcer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marco Meloni Research Topics

Disease

13	Ulcer 06/2022 - 05/2009
11	Wounds and Injuries (Trauma) 03/2022 - 05/2009
9	Diabetic Foot 05/2022 - 09/2014
9	Ischemia 06/2016 - 07/2008
8	Foot Ulcer 12/2022 - 06/2016
8	Myocardial Infarction 01/2022 - 03/2010
7	Infections 03/2022 - 06/2016
7	Chronic Limb-Threatening Ischemia 09/2020 - 12/2012
6	Infarction (Infarctions) 01/2022 - 03/2006
4	Inflammation (Inflammations) 01/2021 - 03/2008
4	Diabetes Mellitus 12/2012 - 04/2009
3	Heart Failure 06/2020 - 03/2010
3	Diabetic Cardiomyopathies 01/2012 - 03/2008
2	Osteomyelitis 05/2022 - 11/2020
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2020
2	Cicatrix (Scar) 01/2022 - 03/2010
2	Type 2 Diabetes Mellitus (MODY) 01/2022 - 01/2013
2	Chronic Kidney Failure (Chronic Renal Failure) 06/2020 - 01/2018
2	Hypertension (High Blood Pressure) 06/2016 - 08/2005
2	Hypoxia (Hypoxemia) 01/2015 - 01/2013
1	Pain (Aches) 06/2022
1	Dementia (Dementias) 01/2022
1	Alzheimer Disease (Alzheimer's Disease) 01/2022
1	Cognitive Dysfunction 01/2022
1	Amyloidosis 01/2022
1	Insulin Resistance 01/2022
1	Neuroinflammatory Diseases 01/2022
1	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2021
1	COVID-19 07/2020
1	Chronic Renal Insufficiency 01/2020
1	Tetralogy of Fallot (Fallot Tetralogy) 12/2019
1	Pulmonary Valve Insufficiency (Insufficiency, Pulmonary Valve) 12/2019
1	Arteriovenous Fistula 01/2018
1	Ventricular Remodeling 01/2017
1	Carotid Artery Diseases 06/2016
1	Acidosis 01/2016
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 05/2015
1	Myocardial Ischemia (Ischemic Heart Diseases) 04/2015
1	Renal Insufficiency (Renal Failure) 04/2015
1	Diabetes Complications 04/2015

Drug/Important Bio-Agent (IBA)

5	Streptozocin (Streptozotocin)FDA Link 12/2012 - 03/2008
4	Matrix Metalloproteinases (MMPs)IBA 01/2017 - 09/2014
3	CollagenIBA 12/2022 - 05/2009
3	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 03/2010
3	Peptide Hydrolases (Proteases)FDA Link 01/2017 - 04/2015
3	Nerve Growth Factor (NGF)IBA 12/2015 - 04/2010
3	Apolipoprotein A-I (Apolipoprotein A1)IBA 02/2011 - 03/2008
2	Oxygen (Dioxygen)IBA 06/2022 - 01/2013
2	Insulin (Novolin)FDA Link 01/2022 - 01/2016
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2013
1	Colloids (Colloid)IBA 03/2022
1	OligosaccharidesIBA 03/2022
1	sucrose octasulfateIBA 03/2022
1	mirdametinibIBA 01/2022
1	Propranolol (Inderal)FDA LinkGeneric 01/2021
1	Gentamicins (Gentamicin)FDA LinkGeneric 11/2020
1	Calcium Sulfate (Alabaster)IBA 11/2020
1	Durapatite (Hydroxylapatite)IBA 11/2020
1	Superoxides (Superoxide)IBA 01/2020
1	Antidepressive Agents (Antidepressants)IBA 01/2020
1	anillinIBA 01/2020
1	phorbolIBA 01/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2019
1	Iloprost (Ventavis)FDA Link 01/2019
1	ProcalcitoninIBA 01/2019
1	Epoprostenol (Prostacyclin)FDA LinkGeneric 01/2019
1	Heme Oxygenase-1IBA 01/2017
1	diazonaphthalenedisulfonic acid (NDS)IBA 06/2016
1	Transient Receptor Potential ChannelsIBA 01/2016
1	ChemokinesIBA 04/2015
1	angiogeninIBA 04/2015
1	TransactIBA 04/2015
1	Pancreatic Elastase (Elastase)IBA 04/2015
1	Proteins (Proteins, Gene)FDA Link 01/2015
1	Messenger RNA (mRNA)IBA 01/2015
1	3-deazaneplanocinIBA 01/2015
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2015
1	Sirolimus (Rapamycin)FDA Link 09/2014
1	ResveratrolIBA 09/2014
1	AlginatesIBA 08/2013
1	Glucagon-Like Peptide 1 (GLP 1)IBA 08/2013
1	Nerve Growth Factor Receptor (Nerve Growth Factor Receptor, Low Affinity)IBA 12/2012
1	NeuropeptidesIBA 04/2012
1	Substance PIBA 04/2012

Therapy/Procedure

16	Surgical Amputation (Amputations) 06/2022 - 01/2013
5	Therapeutics 01/2022 - 05/2015
4	Limb Salvage 09/2020 - 01/2018
3	Cell- and Tissue-Based Therapy (Cell Therapy) 02/2022 - 04/2015
3	Transplantation 04/2015 - 04/2012
2	Debridement 11/2020 - 01/2019
1	Conservative Treatment 05/2022
1	Length of Stay 01/2021
1	Endovascular Procedures 09/2020
1	Bioprosthesis 12/2019
1	Catheters 01/2018
1	Operative Surgical Procedures 05/2015
1	Negative-Pressure Wound Therapy 05/2015
1	Cell Transplantation 05/2015
1	Rejuvenation 09/2014
1	Microspheres (Microsphere) 08/2013